The time has come. The DEA must immediately deschedule 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) from Schedule I of the Controlled Substances Act. The 2011 permanent scheduling (following the 2004 emergency placement) was built on outdated, incomplete science, anecdotal overreach, and a failure to adapt to emerging evidence. Today, with overwhelming evidence of endogenous human production, demonstrated safety, no […]